Arrowstreet Capital’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,919
Closed -$195K 1615
2021
Q2
$195K Sell
1,919
-18,667
-91% -$1.89M ﹤0.01% 1787
2021
Q1
$2.08M Buy
20,586
+2,805
+16% +$288K ﹤0.01% 1556
2020
Q4
$1.96M Buy
17,781
+4,854
+38% +$516K ﹤0.01% 1603
2020
Q3
$1.36M Buy
+12,927
New +$1.34M ﹤0.01% 1719

Other funds holding CELU

Arrowstreet Capital's CELU Position: Q3 2021 in Review

Arrowstreet Capital sold out of Celularity (CELU) in Q3 2021, closing a stake of 1,919 shares — an estimated $195K sold.

Arrowstreet Capital first reported a position in CELU in Q3 2020 and held it in 4 quarters. The position peaked at $2.08M in Q1 2021. 21 funds tracked by Wall St. Rank hold CELU as of Q3 2021.

  • Arrowstreet Capital reported no remaining Celularity position as of Q3 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 1,919 Celularity shares in Q3 2021, an estimated $195K.
  • Arrowstreet Capital first reported a position in Celularity in Q3 2020 and held it in 4 quarters.
  • Arrowstreet Capital's Celularity position peaked at $2.08M in Q1 2021.
  • 21 funds tracked by Wall St. Rank held Celularity as of Q3 2021.

Based on Arrowstreet Capital's 13F filing for Q3 2021, filed 12 Nov 2021.